Electrodialysis with porous membrane (EDPM) is a lately developed membrane separation course of, by which a number of porous filtration membranes stacked in an electrodialysis cell. It’s a promising know-how for separation, purification or focus of bioactive parts for it associates the superb properties of electrodialysis (ED), porous filtration membrane, and electrophoresis. There are a variety of research having tried to optimize the efficiency of EDPM processing, nevertheless, it nonetheless has some limitations involving low productiveness with one pair of separation unit, membrane fouling and few functions on the fractionation of parts with excessive molecular weight.
This paper affords a complete overview of current research dedicated to EDPM, together with rules, configurations, mathematical mannequin concerning mass switch, course of efficiency optimization, membrane fouling and functions in as a lot element as doable. As well as, a set of different separation applied sciences based mostly on electrophoresis at a preparative scale are offered as an example their limitations on the large-scale utility. Some drawbacks of EDPM have been put ahead. To attain full scale functions of EDPM, there are nonetheless many points to beat. Lastly, an outlook for potential improvement of EDPM know-how is given.
Salt-leaching is taken into account to be a serious methodology for soil desalting in agriculture. Due to this fact, conservation of soil diet is important to soil fertility and surroundings safety in the course of the salt-leaching course of. The impact of poly-γ-glutamic acid bioproduct (PGAB), which was manufactured by solid-state fermentation with the micro organism producing glutamic acid (GA) and poly-γ-glutamic acid (γ-PGA) and natural waste, on holding nitrogen (N) throughout salt-leaching was investigated on this examine.
The remoted micro organism producing GA and γ-PGA had been recognized as Brevibacterium flavum and Bacillus amyloliquefaciens, respectively. After the saline soil was leached for 90 days, in comparison with the management, soil salinity (0-30 cm) within the PGAB therapy was decreased by 39.9%, whereas soil complete N was considerably (P < 0.05) larger than different therapies.
Biotransformation of Animal Fats-By Merchandise into ARA-Enriched Fermented Bioproducts by Stable-State Fermentation of Mortierella alpina
Stable-state fermentation (SSF) is a robust fermentation know-how for valorizing relaxation supplies and by-products of various origin. Oleaginous Zygomycetes fungi are sometimes utilized in SSF as an efficient cell manufacturing unit in a position to valorize a variety of hydrophilic and hydrophobic substrates and produce lipid-enriched bioproducts. On this examine, for the primary time, the pressure Mortierella alpina was utilized in SSF for the bioconversion of animal fats by-products into excessive worth fermented bioproducts enriched with arachidonic acid (ARA).
Two cereals-based matrixes combined with 4 totally different concentrations of animal fats by-product had been evaluated for locating optimum circumstances of a fat-based SSF. All obtained fermented bioproducts had been discovered to be enriched with ARA. The best substrate utilization (25.8%) was reached for cornmeal and it was virtually double than for the respective wheat bran samples. Equally, complete fatty acid content material in a fermented bioproduct ready on cornmeal is sort of 4 instances larger in distinction to wheat bran-based bioproduct. Though normally the addition of an animal fats by-product prompted a gradual cessation of ARA yield within the obtained fermented bioproduct, the content material of ARA in fungal biomass was larger.
Thus, M. alpina CCF2861 successfully remodeled exogenous fatty acids from animal fats substrate to ARA. Most yield of 32.1 mg of ARA/g of bioproduct was reached when utilizing cornmeal combined with 5% (w/w) of an animal fats by-product as substrate. Moreover, implementation of attenuated complete reflectance Fourier rework infrared (ATR-FTIR) spectroscopy in characterization of obtained SSF bioproducts was efficiently examined instead software for advanced evaluation, in comparison with conventional time-consuming strategies.
Current advances on conversion and co-production of acetone-butanol-ethanol into excessive value-added bioproducts.
Butanol is a crucial bulk chemical and has been thought to be a sophisticated biofuel. Giant-scale manufacturing of butanol has been utilized for greater than 100 years, however its manufacturing by acetone-butanol-ethanol (ABE) fermentation course of by solventogenic Clostridium species remains to be not economically viable as a result of low butanol titer and yield brought on by the toxicity of butanol and a by-product, akin to acetone. Renewed curiosity in biobutanol as a biofuel has spurred technological advances to pressure modification and fermentation course of design.
Particularly, with the event of interdisciplinary processes, the only product and even the combination of ABE produced by ABE fermentation course of could be additional used as platform chemical compounds for prime worth added product manufacturing by enzymatic or chemical catalysis. This evaluation goals to comprehensively summarize the latest advances on the conversion of acetone, butanol and ABE combination into numerous merchandise, akin to isopropanol, butyl-butyrate and higher-molecular mass alkanes. Moreover, co-production of different worth added merchandise with ABE was additionally mentioned.
The transformation of residual biomass from bioremediation processes into new merchandise is a worldwide pattern pushed by financial, environmental and social achieve. The current examine aimed to judge the potential for acquiring bioproducts of technological curiosity from the remaining periphytic biomass fashioned throughout a bioremediation course of with an algal turf scrubber (ATS) system put in in a lake catchment. Totally different methodologies had been used in response to the goal bioproduct.
CXXC5 Antibody |
|||
| 1-CSB-PA741975LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against CXXC5. Recognizes CXXC5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
CXXC5 Antibody |
|||
| 1-CSB-PA565730 | Cusabio |
|
|
|
Description: A polyclonal antibody against CXXC5. Recognizes CXXC5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:200-1:1000, IHC:1:50-1:200 |
|||
CXXC5 Antibody |
|||
| E036381 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
CXXC5 Antibody |
|||
| E301987 | EnoGene | 100ug/200ul | EUR 295 |
|
Description: Available in various conjugation types. |
|||
CXXC5 Antibody |
|||
| E308323 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
CXXC5 Antibody |
|||
| MBS150962-01mg | MyBiosource | 0.1mg | EUR 445 |
CXXC5 Antibody |
|||
| MBS150962-5x01mg | MyBiosource | 5x0.1mg | EUR 1965 |
CXXC5 Antibody |
|||
| MBS7005820-005mg | MyBiosource | 0.05mg | EUR 190 |
CXXC5 Antibody |
|||
| MBS7005820-01mg | MyBiosource | 0.1mg | EUR 270 |
CXXC5 Antibody |
|||
| MBS7005820-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
CXXC5 Antibody |
|||
| MBS7125367-005mL | MyBiosource | 0.05mL | EUR 190 |
CXXC5 Antibody |
|||
| MBS7125367-01mL | MyBiosource | 0.1mL | EUR 270 |
CXXC5 Antibody |
|||
| MBS7125367-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
CXXC5 Antibody |
|||
| MBS7125368-005mL | MyBiosource | 0.05mL | EUR 190 |
CXXC5 Antibody |
|||
| MBS7125368-01mL | MyBiosource | 0.1mL | EUR 270 |
CXXC5 Antibody |
|||
| MBS7125368-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
CXXC5 Antibody |
|||
| MBS9603606-01mL | MyBiosource | 0.1mL | EUR 260 |
CXXC5 Antibody |
|||
| MBS9603606-02mL | MyBiosource | 0.2mL | EUR 305 |
CXXC5 Antibody |
|||
| MBS9603606-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
CXXC5 Antibody |
|||
| MBS9406734-01mL | MyBiosource | 0.1mL | EUR 305 |
CXXC5 Antibody |
|||
| MBS9406734-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
CXXC5 Antibody |
|||
| MBS9412075-01mL | MyBiosource | 0.1mL | EUR 495 |
CXXC5 Antibody |
|||
| MBS9412075-5x01mL | MyBiosource | 5x0.1mL | EUR 2075 |
CXXC5 Antibody |
|||
| MBS8576209-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
CXXC5 Antibody |
|||
| MBS8576209-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
CXXC5 Antibody |
|||
| MBS8576209-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
CXXC5 Antibody |
|||
| MBS8576209-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
CXXC5 Antibody |
|||
| MBS8576209-02mL | MyBiosource | 0.2mL | EUR 345 |
anti- CXXC5 antibody |
|||
| FNab02113 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against CXXC5 |
|||
Polyclonal CXXC5 Antibody |
|||
| APR06686G | Leading Biology | 0.1 mg | EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CXXC5 . This antibody is tested and proven to work in the following applications: |
|||
CXXC5 Antibody (N-Term) |
|||
| E45R04949G-1 | EnoGene | 100 ul | EUR 395 |
CXXC5 Antibody (N-Term) |
|||
| E45R04949G-4 | EnoGene | 50 ul | EUR 295 |
CXXC5 Antibody (N-Term) |
|||
| MBS9216946-005mL | MyBiosource | 0.05mL | EUR 210 |
CXXC5 Antibody (N-Term) |
|||
| MBS9216946-02mL | MyBiosource | 0.2mL | EUR 430 |
CXXC5 Antibody (N-Term) |
|||
| MBS9216946-5x02mL | MyBiosource | 5x0.2mL | EUR 1910 |
CXXC5 Polyclonal Antibody |
|||
| A65418 | EpiGentek |
|
|
CXXC5 Conjugated Antibody |
|||
| C36381 | SAB | 100ul | EUR 476.4 |
CXXC5 Polyclonal Antibody |
|||
| MBS2520932-002mL | MyBiosource | 0.02mL | EUR 140 |
CXXC5 Polyclonal Antibody |
|||
| MBS2520932-006mL | MyBiosource | 0.06mL | EUR 180 |
CXXC5 Polyclonal Antibody |
|||
| MBS2520932-012mL | MyBiosource | 0.12mL | EUR 260 |
CXXC5 Polyclonal Antibody |
|||
| MBS2520932-02mL | MyBiosource | 0.2mL | EUR 405 |
CXXC5 Polyclonal Antibody |
|||
| MBS2524536-002mL | MyBiosource | 0.02mL | EUR 140 |
CXXC5 Polyclonal Antibody |
|||
| MBS2524536-006mL | MyBiosource | 0.06mL | EUR 180 |
CXXC5 Polyclonal Antibody |
|||
| MBS2524536-012mL | MyBiosource | 0.12mL | EUR 260 |
CXXC5 Polyclonal Antibody |
|||
| MBS2524536-02mL | MyBiosource | 0.2mL | EUR 405 |
CXXC5 Conjugated Antibody |
|||
| MBS9446840-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
CXXC5 Conjugated Antibody |
|||
| MBS9446840-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
CXXC5 Conjugated Antibody |
|||
| MBS9446840-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
CXXC5 Conjugated Antibody |
|||
| MBS9446840-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
CXXC5 Conjugated Antibody |
|||
| MBS9446840-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
CXXC5 Antibody, HRP conjugated |
|||
| 1-CSB-PA741975LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against CXXC5. Recognizes CXXC5 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
CXXC5 Antibody; HRP conjugated |
|||
| MBS7005398-005mg | MyBiosource | 0.05mg | EUR 190 |
CXXC5 Antibody; HRP conjugated |
|||
| MBS7005398-01mg | MyBiosource | 0.1mg | EUR 270 |
CXXC5 Antibody; HRP conjugated |
|||
| MBS7005398-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
CXXC5 Antibody, FITC conjugated |
|||
| 1-CSB-PA741975LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against CXXC5. Recognizes CXXC5 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
CXXC5 Antibody; FITC conjugated |
|||
| MBS7002419-005mg | MyBiosource | 0.05mg | EUR 190 |
CXXC5 Antibody; FITC conjugated |
|||
| MBS7002419-01mg | MyBiosource | 0.1mg | EUR 270 |
CXXC5 Antibody; FITC conjugated |
|||
| MBS7002419-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OACA05046-50UG - CXXC5 Antibody |
|||
| OACA05046-50UG | Aviva Systems Biology | 50ug | EUR 179 |
CXXC5 Antibody, Biotin conjugated |
|||
| 1-CSB-PA741975LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against CXXC5. Recognizes CXXC5 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
CXXC5 Antibody; Biotin conjugated |
|||
| MBS7002645-005mg | MyBiosource | 0.05mg | EUR 190 |
CXXC5 Antibody; Biotin conjugated |
|||
| MBS7002645-01mg | MyBiosource | 0.1mg | EUR 270 |
CXXC5 Antibody; Biotin conjugated |
|||
| MBS7002645-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OACA05046-100UG - CXXC5 Antibody |
|||
| OACA05046-100UG | Aviva Systems Biology | 100ug | EUR 319 |
Rabbit Polyclonal CXXC5 Antibody |
|||
| TA319927 | Origene Technologies GmbH | 100 µg | Ask for price |
CXXC5 Rabbit Polyclonal Antibody |
|||
| E10G08191 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
CXXC5 Rabbit Polyclonal Antibody |
|||
| E10G01244 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Polyclonal CXXC5 Antibody (N-Term) |
|||
| APR04949G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CXXC5 (N-Term). This antibody is tested and proven to work in the following applications: |
|||
Cxxc5 Antibody - N-terminal region |
|||
| MBS3214054-01mL | MyBiosource | 0.1mL | EUR 455 |
Cxxc5 Antibody - N-terminal region |
|||
| MBS3214054-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx301437-100g | Abbexa | 100 µg | EUR 362.5 |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| 20-abx301437 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx301437-20g | Abbexa | 20 µg | EUR 162.5 |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx301437-50g | Abbexa | 50 µg | EUR 250 |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx241495-100g | Abbexa | 100 µg | EUR 350 |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| 20-abx241495 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx241495-10g | Abbexa | 10 µg | EUR 250 |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx241495-200g | Abbexa | 200 µg | Ask for price |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| 20-abx241758 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx241758-96tests | Abbexa | 96 tests | EUR 250 |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx232113-100g | Abbexa | 100 µg | EUR 350 |
CXXC Finger Protein 5 (CXXC5) Antibody |
|||
| abx232113-100ug | Abbexa | 100 ug | EUR 577.2 |
Polyclonal CXXC5 Antibody (N-Terminus) |
|||
| APR02864G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CXXC5 (N-Terminus). This antibody is tested and proven to work in the following applications: |
|||
CXXC Finger Protein 5 (CXXC5) Antibody (HRP) |
|||
| abx307796-100g | Abbexa | 100 µg | EUR 362.5 |
CXXC Finger Protein 5 (CXXC5) Antibody (HRP) |
|||
| 20-abx307796 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody (HRP) |
|||
| abx307796-20g | Abbexa | 20 µg | EUR 162.5 |
CXXC Finger Protein 5 (CXXC5) Antibody (HRP) |
|||
| abx307796-50g | Abbexa | 50 µg | EUR 250 |
CXXC Finger Protein 5 (CXXC5) Antibody (FITC) |
|||
| abx307797-100g | Abbexa | 100 µg | EUR 362.5 |
CXXC Finger Protein 5 (CXXC5) Antibody (FITC) |
|||
| 20-abx307797 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody (FITC) |
|||
| abx307797-20g | Abbexa | 20 µg | EUR 162.5 |
CXXC Finger Protein 5 (CXXC5) Antibody (FITC) |
|||
| abx307797-50g | Abbexa | 50 µg | EUR 250 |
CXXC Finger Protein 5 (CXXC5) Antibody (Biotin) |
|||
| abx307798-100g | Abbexa | 100 µg | EUR 362.5 |
CXXC Finger Protein 5 (CXXC5) Antibody (Biotin) |
|||
| 20-abx307798 | Abbexa |
|
|
CXXC Finger Protein 5 (CXXC5) Antibody (Biotin) |
|||
| abx307798-20g | Abbexa | 20 µg | EUR 162.5 |
CXXC Finger Protein 5 (CXXC5) Antibody (Biotin) |
|||
| abx307798-50g | Abbexa | 50 µg | EUR 250 |
CXXC5 Polyclonal Antibody, HRP Conjugated |
|||
| A65419 | EpiGentek |
|
|
Polyclonal Cxxc5 Antibody - N-terminal region |
|||
| APR01390G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Cxxc5 - N-terminal region. This antibody is tested and proven to work in the following applications: |
|||
CXXC5 Polyclonal Antibody, FITC Conjugated |
|||
| A65420 | EpiGentek |
|
|
CXXC5 Polyclonal Antibody, Biotin Conjugated |
|||
| A65421 | EpiGentek |
|
|
CXXC5 |
|||
| CSB-CL741975HU1 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
CXXC5 |
|||
| CSB-CL741975HU2 | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
ARP58792_P050-25UL - Cxxc5 Antibody - N-terminal region |
|||
| ARP58792_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP58792_P050 - Cxxc5 Antibody - N-terminal region (ARP58792_P050) |
|||
| ARP58792_P050 | Aviva Systems Biology | 100ul | EUR 389 |
Cxxc5 (GFP-tagged) - Mouse CXXC finger 5 (Cxxc5) |
|||
| MG204551 | Origene Technologies GmbH | 10 µg | Ask for price |
CXXC5 (untagged)-Human CXXC finger protein 5 (CXXC5) |
|||
| SC317489 | Origene Technologies GmbH | 10 µg | Ask for price |
CXXC5 (untagged)-Human CXXC finger protein 5 (CXXC5) |
|||
| SC319180 | Origene Technologies GmbH | 10 µg | Ask for price |
CXXC5 Peptide |
|||
| 6111P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (NT) CXXC5 peptide |
|||
CXXC5 Peptide |
|||
| MBS153075-005mg | MyBiosource | 0.05mg | EUR 175 |
CXXC5 Peptide |
|||
| MBS153075-5x005mg | MyBiosource | 5x0.05mg | EUR 770 |
Cxxc5 (Myc-DDK-tagged) - Mouse CXXC finger 5 (Cxxc5) |
|||
| MR204551 | Origene Technologies GmbH | 10 µg | Ask for price |
CXXC5 (GFP-tagged) - Human CXXC finger protein 5 (CXXC5) |
|||
| RG202963 | Origene Technologies GmbH | 10 µg | Ask for price |
Cxxc5 (untagged ORF) - Rat CXXC finger 5 (Cxxc5), (10 ug) |
|||
| RN203353 | Origene Technologies GmbH | 10 µg | Ask for price |
CXXC5 (Myc-DDK-tagged)-Human CXXC finger protein 5 (CXXC5) |
|||
| RC202963 | Origene Technologies GmbH | 10 µg | Ask for price |
Rat CXXC5 siRNA |
|||
| 20-abx913288 | Abbexa |
|
|
CXXC5 siRNA (Rat) |
|||
| MBS8228621-15nmol | MyBiosource | 15nmol | EUR 405 |
CXXC5 siRNA (Rat) |
|||
| MBS8228621-30nmol | MyBiosource | 30nmol | EUR 565 |
CXXC5 siRNA (Rat) |
|||
| MBS8228621-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
CXXC5 cDNA Clone |
|||
| MBS1275102-001mgPlasmid02mLGlycerolStock | MyBiosource | 0.01mgPlasmid+0.2mLGlycerol-Stock | EUR 330 |
CXXC5 cDNA Clone |
|||
| MBS1275102-5x001mgPlasmid5x02mLGlycerolStock | MyBiosource | 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock | EUR 1450 |
CXXC5 cDNA Clone |
|||
| MBS1275507-001mgPlasmid02mLGlycerolStock | MyBiosource | 0.01mgPlasmid+0.2mLGlycerol-Stock | EUR 200 |
CXXC5 cDNA Clone |
|||
| MBS1275507-5x001mgPlasmid5x02mLGlycerolStock | MyBiosource | 5x0.01mgPlasmid+5x0.2mLGlycerol-Stock | EUR 855 |
CXXC5 Rabbit pAb |
|||
| E2822172 | EnoGene | 100ul | EUR 225 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Human CXXC5 siRNA |
|||
| 20-abx901358 | Abbexa |
|
|
Mouse CXXC5 siRNA |
|||
| 20-abx913289 | Abbexa |
|
|
CXXC5 siRNA (Human) |
|||
| MBS8213261-15nmol | MyBiosource | 15nmol | EUR 405 |
CXXC5 siRNA (Human) |
|||
| MBS8213261-30nmol | MyBiosource | 30nmol | EUR 565 |
CXXC5 siRNA (Human) |
|||
| MBS8213261-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
CXXC5 siRNA (Mouse) |
|||
| MBS8200533-15nmol | MyBiosource | 15nmol | EUR 405 |
CXXC5 siRNA (Mouse) |
|||
| MBS8200533-30nmol | MyBiosource | 30nmol | EUR 565 |
CXXC5 siRNA (Mouse) |
|||
| MBS8200533-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
CXXC5 cloning plasmid |
|||
| CSB-CL741975HU1-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the CXXC5 gene. |
|||
CXXC5 cloning plasmid |
|||
| CSB-CL741975HU2-10ug | Cusabio | 10ug | EUR 457.2 |
|
Description: A cloning plasmid for the CXXC5 gene. |
|||
CXXC5 Blocking Peptide |
|||
| DF12378-BP | Affbiotech | 1mg | EUR 234 |
Analyses had been carried out by excessive efficiency liquid chromatography with diode array detector (HPLC/DAD), fuel chromatography mass spectrometry (GC-MS), ultraviolet-visible spectroscopy (UV-VIS) and inductively coupled plasma optical emission spectrometry (ICP-OES).